← Scoopfeeds — Intelligent news, curated.
Mineralys Therapeutics CEO Jon Congleton sells $1.96m in stock
business

Mineralys Therapeutics CEO Jon Congleton sells $1.96m in stock

Investing.com · Jun 30, 2026, 10:45 PM · Also reported by 3 other sources

Mineralys Therapeutics CEO Jon Congleton sells $1.96m in stock

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Is MapLight Therapeutics, Inc. (MPLT) Stock a Biotech Opportunity Ahead of the ZEPHYR Trial Readout? Yahoo Finance Is Celldex Therapeutics, Inc. (CLDX) Stock Positioned for Growth Ahead of Potential 2027 Approval? Yahoo Finance Is Definium Therapeutics, Inc. (DFTX) Stock Poised for Further Gains After Positive Emerge Trial Update?

More in business

Investing.com
Yen sinks to four-decade low as dollar gets yields boost
Financial Times
US Supreme Court checks Trump’s power even as it bolsters the presidency
Investing.com
Form 144 UMB FINANCIAL CORP For: 30 June
Investing.com
Form 144 UMB FINANCIAL CORP For: 30 June
Investing.com
Japan manufacturing extends growth, caps best quarter since Q1 2014, PMI shows
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop